Shuji Ikegami

Publication Activity (10 Years)

Years Active: 2023-2023
Publications (10 Years): 3

Top Topics

Prognostic Factors

Chronic Kidney Disease

Ejection Fraction

Ulcerative Colitis

Top Venues

Alimentary pharmacology & therapeutics

This page only lists publications with an associated author ORCID identifier.

Publications

Shuji Ikegami, Masanao Nakamura, Takashi Honda, Hiroki Kawashima
Letter: 1-kestose, the smallest fructooligosaccharide component, protection for mild to moderate ulcerative colitis patients-authors' reply. Alimentary pharmacology & therapeutics 57 (11) (2023)
Shuji Ikegami, Masanao Nakamura, Takashi Honda, Takeshi Yamamura, Keiko Maeda, Tsunaki Sawada, Eri Ishikawa, Kenta Yamamoto, Satoshi Furune, Takuya Ishikawa, Kazuhiro Furukawa, Eizaburo Ohno, Masatoshi Ishigami, Fumie Kinoshita, Yoshihiro Kadota, Takumi Tochio, Yoshiharu Shimomura, Yoshiki Hirooka, Hiroki Kawashima
Efficacy of 1-kestose supplementation in patients with mild to moderate ulcerative colitis: A randomised, double-blind, placebo-controlled pilot study. Alimentary pharmacology & therapeutics (2023)
Shuji Ikegami, Masanao Nakamura, Takashi Honda, Hiroki Kawashima
Letter: 1-kestose, the smallest fructooligosaccharide component, protection for mild to moderate ulcerative colitis patients-authors' reply. Alimentary pharmacology & therapeutics 57 (11) (2023)